|
|
|
|
STaR Study: Association of Efficacy Outcomes with Baseline HIV-1 RNA and CD4 Count and Adherence
Rate for the Single-Tablet Regimens Rilpivirine/Emtricitabine/Tenofovir DF and Efavirenz/Emtricitabine/Tenofovir DF
in ART-Naïve Adults
|
|
|
Reported by Jules Levin
IDSA Oct 2-6 2013, San Francsisco, CA
Calvin Cohen, David Wohl, Keith Henry, William Towner, Edmund
Wilkins, Ramin Ebrahimi, Danielle Porter, Valeska Scharen-Guivel, Todd
Fralich, Shampa De-Oertel
|
|
|
|
|
|
|